Literature DB >> 18611102

Stroke and TIA: epidemiology, risk factors, and the need for early intervention.

Marc Fisher1.   

Abstract

The risk of recurrent stroke in patients who have suffered a prior stroke or transient ischemic attack (TIA) is significant. It is imperative that individuals who report symptoms of a cerebrovascular event receive immediate medical attention--preferably at a hospital--to help determine its origin and impact. Many researchers recommend that any evaluation include neuroimaging studies to target those patients who would benefit most from secondary prevention, such as antithrombotic therapy. This article defines the 2 main types of stroke and their respective subtypes and discusses the debate over how to define stroke versus TIA. Additionally, the article talks about the incidence of stroke, related morbidity and mortality rates, and several risk factors that predispose an individual to stroke and recurrent stroke. Several systems have been established to help determine the likelihood of stroke for patients with concurrent risk factors. Measures for secondary prevention can be initiated to address many of these risk factors. The importance of early intervention cannot be underestimated. Rapid treatment following a stroke or TIA can minimize cerebrovascular damage and prevent recurrence; addressing modifiable risk factors can reduce the risk of subsequent cardiovascular and cerebrovascular events. Facilitating the initiation of effective secondary preventive therapy must become a priority in managed care.

Entities:  

Mesh:

Year:  2008        PMID: 18611102

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  17 in total

Review 1.  Neurothrombectomy in the treatment of acute ischaemic stroke.

Authors:  Olav Jansen; Axel Rohr
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 2.  Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients.

Authors:  H S Kirshner
Journal:  J Neurol       Date:  2010-07-22       Impact factor: 4.849

Review 3.  In vivo animal stroke models: a rationale for rodent and non-human primate models.

Authors:  Naoki Tajiri; Travis Dailey; Christopher Metcalf; Yusef I Mosley; Tsz Lau; Meaghan Staples; Harry van Loveren; Seung U Kim; Tetsumori Yamashima; Takao Yasuhara; Isao Date; Yuji Kaneko; Cesario V Borlongan
Journal:  Transl Stroke Res       Date:  2013-06       Impact factor: 6.829

4.  Predictors of prognosis for elderly patients with poststroke hemiplegia experiencing hip fractures.

Authors:  Mingli Feng; Jian Zhang; Huiliang Shen; Huaijian Hu; Li Cao
Journal:  Clin Orthop Relat Res       Date:  2009-04-15       Impact factor: 4.176

Review 5.  Cellular and molecular neurobiology of brain preconditioning.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Mol Neurobiol       Date:  2009-01-20       Impact factor: 5.590

Review 6.  Update of the stroke therapy academic industry roundtable preclinical recommendations.

Authors:  Marc Fisher; Giora Feuerstein; David W Howells; Patricia D Hurn; Thomas A Kent; Sean I Savitz; Eng H Lo
Journal:  Stroke       Date:  2009-02-26       Impact factor: 7.914

7.  A cluster randomized trial to assess the effect of clinical pathways for patients with stroke: results of the clinical pathways for effective and appropriate care study.

Authors:  Massimiliano Panella; Sara Marchisio; Romeo Brambilla; Kris Vanhaecht; Francesco Di Stanislao
Journal:  BMC Med       Date:  2012-07-10       Impact factor: 8.775

8.  A Q-Methodology Study of Patients' Subjective Experiences of TIA.

Authors:  Laura Spurgeon; Glyn Humphreys; Gill James; Cath Sackley
Journal:  Stroke Res Treat       Date:  2012-07-03

9.  A Systematic Review of the Predictive Value of Plasma D-Dimer Levels for Predicting Stroke Outcome.

Authors:  Peng Zhang; Chun Wang; Junhua Wu; Shiliang Zhang
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

10.  Multimodal endovascular management of acute ischemic stroke in patients over 75 years old is safe and effective.

Authors:  George M Ghobrial; Nohra Chalouhi; Lana Rivers; Samantha Witte; Justin Davanzo; Richard Dalyai; Michelle L Gardecki; Pascal Jabbour; Fernando Gonzalez; Aaron S Dumont; Robert H Rosenwasser; Stavropoula Tjoumakaris
Journal:  J Neurointerv Surg       Date:  2012-07-11       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.